Gaucher's Disease Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Clinical Trials

Phase 1/2 Study of CAN103 in Newly Treated Subjects With Gaucher Disease
Conditions:   Gaucher Disease, Type 1;   Gaucher Disease, Type 3 Interventions:   Drug: Low-dose CAN103;   Drug: High-dose CAN103 Sponsor:   CANbridge (Suzhou) Bio-pharma Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 7, 2022 Category: Research Source Type: clinical trials

Phase 1/2 Study of CAN103 in Subjects With Gaucher Disease
Conditions:   Gaucher Disease, Type 1;   Gaucher Disease, Type 3 Interventions:   Drug: Low-dose CAN103;   Drug: High-dose CAN103 Sponsor:   CANbridge (Suzhou) Bio-pharma Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 7, 2022 Category: Research Source Type: clinical trials

A Gene Therapy Study in Patients With Gaucher Disease Type 1
Condition:   Gaucher Disease, Type 1 Intervention:   Genetic: FLT201 Sponsor:   Freeline Therapeutics Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 13, 2022 Category: Research Source Type: clinical trials